RESOLVED: Chimerix, a kid and compassionate use
This article was originally published in Scrip
Executive Summary
It's a tough spot for the chief executive of a small biotechnology company to be in: a sick child has run out of treatment options and his doctor and family believe that your unapproved drug is his only hope.